Cyclacel is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders
Keywords: Cyclacel, biopharmaceutical, cell cycle biology, cancer, research drug, chemogenomics, CYC202, CYC682, seliciclib, share price Sapacitabine, Aurora kinase, Cyclacel Pharmaceuticals